K12 Training for Clinical and Translational Oncology Researchers

临床和转化肿瘤学研究人员的 K12 培训

• 批准号: 10647170
• 负责人: Erik Sulman
• 金额: $ 5.35万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-20 至 2028-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10647170
• 关键词: Address; Cancer Patient; Clinical; Clinical Oncology; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Computational Biology; Creativeness; Dedications; Development; Educational Status; Ensure; Exposure to; Faculty; Fostering; Grant; Individual; Informatics; Infrastructure; Institution; Instruction; Investments; Malignant Neoplasms; Manuscripts; Medical Oncologist; Mentored Clinical Scientist Development Program; Mentors; Performance; Preparation; Productivity; Publications; Radiation Oncologist; Research; Research Personnel; Research Project Grants; Resources; Science; Surgical Oncologist; Time; Training; Translational Research; Work; Writing; anticancer research; career; career development; clinical training; cohort; expectation; experience; innovation; multidisciplinary; next generation; preservation; programs; research and development; responsible research conduct; skill acquisition; skills; success; translational impact; translational oncology

Abstract: A critical requirement to sustain the rapid advances in clinical oncology research that have been made over the last 20 years is to train and mentor the next generation of cancer clinician-investigators. Individuals who can write and carry out clinical trials that will promote increasing benefit for cancer patients are a crucial resource that must be preserved. The objectives of the NYU K12 Program are to provide the protected time which will foster the creativity, drive, and intellectual skills necessary to produce investigators who will make the key clinical discoveries in cancer research over the next few decades. We seek to equip scholars with career development skills that will guide them through productive careers as clinician-investigators. This first-time proposal is based on a record of training and mentoring outstanding clinical researchers while serving as junior faculty at NYU, the provision of a strong institutional commitment to support development of clinician investigators, representation of experienced and motivated medical, radiation and surgical oncologists among the mentors, an emphasis on informatics and computational biology and critical infrastructure that is part of an institutional Clinical and Translational Science Institute (CTSI) to leverage the strengths of the greater institution. NYU K12 scholars will complete training on the responsible conduct of research, general and targeted formal didactics instruction addressing proficiency in clinical and translational research, Master’s-level training in multidisciplinary clinical research, specialized course work, training in team science, individualized and didactic training in grant preparation, exposure to alternative career opportunities, and mentored performance of an innovative high- impact translational research project. Expectations at completion include publication of 2-3 first and/or senior author manuscripts and submission of a K- or R-level grant or equivalent. Three scholars yearly will dedicate 75% effort to research and career development activities for up to three years each, supervised by mentors with extensive and outstanding mentoring experience. A strongly invested K12 Executive Committee and a broad and diverse program faculty will promote each scholar’s mentoring. Our first aim is to provide personalized mentoring and didactic training to advance the clinical and translational research careers of our cohort of K12 scholars. Our second aim is to allow the K12 scholars to identify, choose and pursue research opportunities relevant to advancing the field of clinical oncology. Our third aim is to enable K12 scholars to establish multidisciplinary clinical and translational research networks and collaborations to ensure the success of their efforts and promote their careers in clinical oncology research.

抽象的： 维持临床肿瘤学研究快速发展的关键要求 过去 20 年的目标是培训和指导下一代癌症临床医生/研究人员。 撰写和开展临床试验将促进癌症患者的更多利益是重要的资源 纽约大学 K12 项目的目标是提供受保护的时间。 培养培养关键临床研究人员所需的创造力、动力和智力技能 我们寻求未来几十年癌症研究的发现，为学者提供职业发展。 指导他们作为临床医生研究员开展富有成效的职业生涯的技能是这项首次提案的基础。 在担任纽约大学初级教师期间，有培训和指导杰出临床研究人员的记录， 提供强有力的机构承诺来支持临床研究人员的发展、代表性 导师中有经验丰富、积极进取的医学、放射和外科肿瘤学家，重点是 信息学和计算生物学以及作为机构临床和治疗机构一部分的关键基础设施 转化科学研究所 (CTSI) 将充分利用纽约大学 K12 学者的优势。 完成负责任的研究行为、一般和有针对性的正式教学指导的培训 解决临床和转化研究的熟练程度，多学科临床硕士水平的培训 研究、专业课程工作、团队科学培训、赠款中的个性化和教学培训 准备、接触替代职业机会以及指导创新型高水平人才的表现 影响力转化研究项目完成后的预期包括发表 2-3 篇第一和/或高级论文。 作者手稿并提交 K 级或 R 级资助或同等资助，每年将有三名学者奉献。 75% 的精力用于研究和职业发展活动，每次最长三年，由导师监督 广泛而杰出的指导经验。K12 执行委员会投入大力，并且广泛 多样化的项目教师将促进每位学者的指导。我们的首要目标是提供个性化的指导。 指导和教学培训，以促进我们 K12 群体的临床和转化研究职业生涯 我们的第二个目标是让 K12 学者能够识别、选择和追求研究机会。 我们的第三个目标是让 K12 学者能够建立与推进临床肿瘤学领域相关的研究。 多学科临床和转化研究网络和合作，以确保其成功 并促进他们在临床肿瘤学研究中的职业生涯。